Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|October 9, 2024
Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinibMario Manzanares, Fernando Ramos-Martín, Sara Rodríguez-Mora, et al.
Frontiers in Immunology|April 11, 2022
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic BiomarkersMiguel Galán, Lorena Vigón, Daniel Fuertes, et al.
Plos Pathogens|August 30, 2019
The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infectionSara Rodríguez-Mora, Flore De Wit, Javier García-Perez, et al.
Plos One|October 3, 2017
Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cellsMaría Sánchez-Del Cojo, María Rosa López-Huertas, Francisco Díez-Fuertes, et al.
Biochemical Pharmacology|February 7, 2016
Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cellsMercedes Bermejo, María Rosa López-Huertas, Javier García-Pérez, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia VirionsYue Zheng, Erin T Larragoite, Juan Lama, et al.
Virology Journal|January 5, 2021
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virionsYue Zheng, Erin T Larragoite, Elizabeth S C P Williams, et al.
Frontiers in Immunology|May 30, 2024
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virusGuiomar Casado-Fernández, Juan Cantón, Laura Nasarre, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 25, 2022
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin DMontserrat Torres, Guiomar Casado, Lorena Vigón, et al.
Cancers|October 28, 2023
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19Sara Rodríguez-Mora, Magdalena Corona, Miriam Solera Sainero, et al.
Pageof 8